Migraine does not take lives but days from your life. Take them back!
HYPOTHALAMUS AND CEPHALIC PAIN
NEW TARGETS IN MIGRAINE TREATMENT
Gisela Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, the Netherlands. Her PhD encompassed epidemiology and genetics of migraine, with the discovery of the first migraine gene. She is director of the Headache clinic, associate professor of Neurology, and Consultant Neurologist, at the Department of Neurology, Leiden University Medical Center (LUMC), Netherlands,. Gisela Terwindt is chair of the scientific committee and the national migraine guideline committee of the Dutch Headache Society. She is a member of the International Headache Classification Committee and Board member of the IHS. She has published ~200 scientific papers and several book chapters on headache and migraine. She received a prestigious personal grant from the Dutch Organisation of Scientific Research (VIDI award).
My research interests lie in unravelling neurobiological and molecular triggering mechanisms leading to migraine attacks, and identifying treatment targets for the acute treatment and prevention of attacks and disease chronification. In addition, I am studying the pathogenesis of rare monogenic disorders such as FHM (familial hemiplegic migraine) and CHA (Cerebral Hereditary Angiopathies) which may serve as genetic models to study the pathogenesis of migraine but also improve mechanistic insight in the pathophysiology of other common neurovascular disorders, including stroke and dementia. With this, I am increasingly involved in the relationship between migraine and stroke with a special focus on women, and I have a particular interest in studying female-specific trigger factors and complications in migraine.